You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pediatric Hodgkin's Lymphoma high risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Anaplastic Large Cell Lymphoma Trial in Shanghai (P regimen, Course A1 + Vin, Course B1 +Vin)

Recruiting
  • Pediatric Anaplastic Large Cell Lymphoma
  • P regimen
  • +7 more
  • Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

Recruiting
  • Non-hodgkin Lymphoma
  • Hodgkin Lymphoma
  • DOC Group B
  • +16 more
  • Valhalla, New York
    New York Medical College
Jun 9, 2022

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • boost anti-viral immunity after T-cell depleted HSCT
  • Moscow, Russian Federation
    Federal Research Center for pediatric hematology, oncology and i
Oct 1, 2021

Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

Not yet recruiting
  • Non-hodgkin Lymphoma, B Cell
  • ctDNA detection
  • Aarau, Switzerland
  • +12 more
Oct 18, 2023

Quality of Life in Adult and Pediatric Nodular

Recruiting
  • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    • Aurora, Colorado
    • +1 more
    Oct 27, 2023

    Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

    Recruiting
    • Large B-cell Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • Comprehensive Ablative Bridging Irradiation (CABI)
    • Chimeric Antigen Receptor T-Cell Therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 26, 2023

    NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

    Suspended
    • NHL
    • +3 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 31, 2023

    Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

    Terminated
    • Hodgkin's Lymphoma
    • histone deacetylase inhibitor (ITF2357)
    • Milan, Italy
      Istituto Nazionale per lo studio e la cura dei Tumori
    Jan 18, 2022

    Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Pediatric Hodgkin Lymphoma
    • Brentuximab Vedotin (Genetical Recombination)
    • Tokyo, Japan
      Takeda Selected Site
    Oct 11, 2022

    Clinical, Laboratory and Epidemiologic Characterization of

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +4 more
      • Bethesda, Maryland
      • +1 more
      Jan 25, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 22, 2023

      Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

      Not yet recruiting
      • Non-hodgkin Lymphoma
      • +9 more
      • CD79b-19 CAR T cells
      • +2 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 6, 2023

      Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

      Not yet recruiting
      • Hodgkin Lymphoma
      • Brentuximab Vedotin
      • (no location specified)
      Jul 28, 2022

      Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

      Not yet recruiting
      • Mature B-Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 6, 2022

      Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

      Completed
      Has Results
      • Non-Hodgkin's Lymphoma
      • Etoposide, carboplatin, ifosfamide
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      May 23, 2022

      Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 20, 2023

      MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

      Recruiting
      • Myelodysplastic Syndromes, de Novo
      • +10 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 23, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 16, 2023

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

      Not yet recruiting
      • Lymphoma, B-Cell
      • +6 more
      • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
      • Guayaquil, Guayas, Ecuador
        Instituto Oncológico Nacional Dr. Juan Tanca Marengo
      Apr 27, 2023

      Frontline of ASCT in High-risk DLBCL

      Recruiting
      • Diffuse Large B Cell Lymphoma
        • Beijing, Beijing, China
          Peking University People's Hospital
        Apr 26, 2023

        Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

        Recruiting
        • Lymphoma, Large B-Cell, Diffuse
        • Lymphoma, T-Cell
        • Deyang, Deyang, China
        • +10 more
        Jul 21, 2022